General anesthetics cont.

Intravenous anesthetics

GENERAL PROPERTIES OF I.V. ANESTHETICS

Chemical properties

I.v. anesthetics are relatively hydrophobic and lipophilic compounds

Chemical classes

Barbiturates: thiopental, methohexital

propofol, etomidate, ketamine

MOA

All (except ketamine) activate the GABA-A receptor

Barbiturates also inhibit the neuronal N-type acetylcholine receptor

Ketamine inhibits the NMDA-type glutamate receptor

Pharmacokinetics

Tissue distribution and redistribution of i.v. anesthetics

IMMEDIATELY AFTER I.V. INJECTION, they distribute rapidly to the well-perfused tissues,
including the brain → general anesthesia occurs rapidly (within ~ 1 min)

LATER, they redistribute to the less well-perfused tissues, such as the muscle, skin and adipose tissue.
These have large mass → remove the anesthetic from the brain → the patient wakes up in a few minutes

The anesthetic action of i.v. anesthetics is terminated by redistribution, not by elimination.
The rate of redistribution is quite similar for all i.v. anesthetics;
therefore, after a single anesthetic dose, their duration of action is also similar (i.e., 5-10 min).

The rate of redistribution of i.v. anesthetics may decrease in patients with

decreased tissue perfusion (e.g., in cardiac failure and septic shock)

decreased muscle and adipose tissue mass (e.g., in elderly or malnourished patient)

In such conditions, the dose of i.v. anesthetic should be lowered lest the anesthesia should be too long

Elimination of i.v. anesthetics

All i.v. anesthetics are eliminated by biotransformation, e.g., by CYP-catalyzed oxidation (barbiturates,
ketamine), glucuronidation (propofol), and hydrolysis (etomidate)

There are significant differences in the rate of elimination of i.v. anesthetics;
this is reflected in their elimination half-lives

Thiopental is eliminated very slowly: T1/2β = 12 hrs

The others are eliminated relatively rapidly: T1/2 = 1-4 hrs

Propofol is eliminated most rapidly (by glucuronidation); T1/2β = 1-2 hrs.

Clinical use

All may be given as a single dose for

induction of anesthesia before inhalation anesthesia, if the inhal. anesthetic slowly induces anesthesia
(e.g., halothane), or has unpleasant odor or airway irritating property (e.g., isoflurane, desflurane)

short anesthesia for short surgery or painful intervention (e.g., reposition of a dislocated joint)

Some

continuous infusion to produce long-lasting anesthesia.
After discontinuation of the infusion, the patient wakes up in 10 minutes even if propofol was infused
for 3 hours. Propofol is the preferred i.v. anesthetic for TIVA (total intravenous anesthesia). At a lower
dose rate, propofol is also used for continuous sedation of patients in ICUs

Specific properties of I.V. anesthetics

Barbiturates

Thiopental

Methohexital

Dose

Thiopental

Methohexital

1-1.5 mg/kg) i.v.

3-5 mg/kg i.v

Onset of action

~20 sec; induction is rapid and smooth

Duration of action: ~5-10 min, for both

Elimination

CYP

Thipental

methohexial

N-demethylation

Oxidative desulfuration

Both

Hydroxylation on the aliphatic chains linked to C5 of the barb. ring

Half life

Thiopental

12 h

Methohexital

4 h

Advantages

Decrease cerebral metabolic rate and O2 utilization by the brain

Decrease the cerebral blood flow which decreases the incracranial pressure -> decrease of ocular pressure

exert anticonvulsive effect → thiopental is valuable in the treatment of status epilepticus

Disadvantages

Incompatibility

injectible solution is basic, can precipitate as free acid in a acidic solution

Exert vascular irritative effect

If the i.v. injected thiopental conc. is >2.5%, it may induce pain and thrombophlebitis

If injected intra-arterially, it induces endarteritis and gangrene

Barbiturates induce respiratory depression

In asthmatics, they may induce histamine release and wheezing

Barbiturates induce hypotension by causing both

vasodilatation

negative inotropic effect

barbiturates should not be injected:

too rapidly → excessive decrease in cardiac contractility

to a patient who can not compensate for ↓ blood pressure

Barbiturates induce ALA synthetase

First enzyme in heme synthesis

Cause accumulation of porphyrins in patients deficient in some
downstream enzymes of the heme synthetic pathway.

Propofol

Dose

1.5-2.5 mg/kg

Onset and duration of anesthesia

after a bolus dose, anesthesia develops in ~20 sec

recovery

within 10 min after a 3-hr infusion

within 40 min after an 8-hr infusion

Elimination

By glucuronidation (mainly) and sulfation at the hydroxyl group

T1/2β = 2 hrs

Usage

TIVA in infusion

used by orthopedic surgeons in SCOLIOSIS CORRECTION SURGERY

Also used for continuous sedation in intensive care units

Advantages

Propofol ↓ cerebral metabolic rate, O2 consumption
→ ↓ cerebral blood flow, intracranial and intraocular pressure

Propofol has antiemetic effect

Disadvantages

Has venoirritative effect → pain; prevented by lidocaine i.v

Has respiratory depressive effect

Decreases blood pressure because of vasodilatation and negative inotropic effect

Special disadvantages

Propofol is a water immiscible oily substance

emulsion is used as an i.v. anesthetic

Propofol Infusion Syndrome

Occurs with high dose

Mech

Toxic effect on mitrochondria, mainly in skeletal and cardiac muscle

acts as a weak protonophoric uncoupler

Diffuses into Mit., dissociates its phenolic proton, thus dissipating the inwardly directed H+ gradiant that drives ATP synthase.

Consequences

Cardiac failure: acute refractory bradycardia (may lead to asystole), hypotension, and ST elevation

Rhabdomyolysis → ↑serum K+, ↑serum CK, myoglobinuria → renal failure

Hepatomegaly with fatty liver (probably caused by inhibition of fatty acid oxidation)

High serum triglyceride levels

Lactic acidosis

Etomidate

Dose

0.2-0.4 mg/kg

Rapidly and ultra short acting (4-8 min) anesthetic

Elimination

Ester hydrolysis in the liver

T1/2β = 3 hrs

Other disadvantages

often induces nausea and vomiting

appears to have proconvulsive effect (contraindicated in seizures)

causes pain on injection

Advantages

↓ cerebral metabolic rate, O2 consumption → ↓ cerebral blood flow, intracranial and intraocular pressure

little respiratory depression

little or no decrease in blood pressure and may slightly increase the heart rate

→ the CARDIOVASCULAR FUNCTION IS STABLE during etomidate anesthesia → etomidate is usually reserved for patients at risk for hypotension and/or myocardial ischemia

Ketamine

Dose

0.5-1.5 mg/kg

Onset of action

1-2 min

Duration of anesthesia: 10-15 min

Elimination

CYP-catalyzed N-demethylation

T1/2β = 3 hrs

Effects

Analgesic effect

outlasts the anesthetic effect

used by ambulance services for sedation and pain suppression in patients

Induce disagreeable dreams and hallucinations

This occurs seldom in children → ketamine is a preferred anesthetic in pediatric surgery

Indirect sympathomimetic effect

Because it ↓ neuronal reuptake of catecholamines
both peripherally and centrally

↑ blood pressure

↑ heart rate, cardiac output, myocardial O2 consumption

↑ cerebral blood flow, ↑ intracranial pressure

Pupillary dilation, nystagmus, lacrimation

Bronchodilation

Indication

at risk for hypotension

asthmatic

Contraindicated

Risk for myocardial ischemia

↑ intracranial pressure

GENERAL ANESTHETIC PROCEDURES USING OPIOIDS IN COMBINATION WITH BENZODIAZEPINES OR BUTYROPHENONES

Opioids

Preferred opioids

Fentanyl

Sufentanyl

Remifentanyl

Relatively long acting opioid

T1/2 = 4 hrs

100-150 µg/kg

Super potent opioid

0.25-0.5 µg/kg

T1/2 = 2 hrs

ultrashort-acting opioid

T1/2 = 4 min

0.1-0.5 µg/kg/min

may be used for
TIVA with propofol

Unwanted effects

Respiratory depression

Chest wall and laryngeal rigidity

Decreased gastrointestinal and bladder motility

Combination of opioids with benzodiazepines

Effect

Combination of a high dose opioid analgesic with a high dose i.v. benzodiazepine produces a general anesthetic state.

Advantage

The opioid-benzodiazepine combination does not affect cardiac function adversely

This combination is used in patients undergoing cardiac surgery or other major surgery when the patient’s circulatory reserve is limited

Properties

They lack general anesthetic properties

cause amnesia.

competitively antagonized by flumazenil

The benzodiazepines used in anesthetic procedures fall into two categories

Not water-soluble

diazepam, lorazepam

prolonged elimination

non-aqueous vehicle causes pain and irritation upon i.v. administration

Water-soluble

Midazolam

rapidly eliminated

half-life 2-4 hrs

slow-onset CNS depressant (sedative) effect

inadequate alone for surgical anesthesia

Combination of opioids with butyrophenones

Effect

combination of a neuroleptic

fentanyl + droperidol + nitrous oxide → loss of consciousness = Neurolept anesthesia

with a narcotic analgesic drug produces neurolept
analgesia, a state of quiescence with indifference to pain, but with maintained consciousness

Advantage

Consciousness is maintained, permitting communication with the patient

The circulation is not affected adversely

Used when the patient

needs to be communicated with, e.g. during inner ear surgery

impaired cardiac function

Preferred combination

fentanyl plus droperidol

Fixed combination: THALAMONAL

Disadvantage

Neurolept analgesia causes dysphoria, therefore it is rarely used nowadays

PRE- AND POSTANESTHETIC MEDICATION

Objective: To relieve anxiety, induce amnesia, and
to prevent unpleasant dreams caused by
ketamine

Benzodiazepines (midazolam, diazepam, lorazepam)

To extremely concerned patients (cancer, open-heart surg.):
Benzodiazepine + Narcotic analgesic (opioid) + Scopolamine

Objective: To potentiate the action of anesthetics

Benzodiazepines (e.g., midazolam i.v. or i.m.)

Narcotic analgesics (e.g., fentanyl, sufentanyl)

Barbiturates

α2-Receptor agonists

Non-narcotic analgesic (e.g., ketorolac)

Objective: To decrease bronchial/salivary secretions

Atropine

Objective: To prevent aspiration of the gastric juice

H2 rec antagonist + metoclopramide (a prokinetic drug)

Objective: To prevent adverse effects of anesthetics

β-receptor antagonist: against halothane-arrhythmia

Atropine: against halothane-bradycard

Disulfiram: (inhibits CYP2E1): against halothane-hepatitis

To prevent postoperative emesis

To suppress postanesthesia shivering

Post-operative pain control

D2-receptor antagonists: droperidol, metoclopramide

5-HT3 receptor antagonists: ondansetron

Propofol induction (propofol has antiemetic effect)

Opioids lower the shivering trigger-temperature

Opioids (e.g., fentanyl)

NSAIDs (e.g., ketorolac, 30-60 mg i.v.)